Bacteriophage Production in Compliance with Regulatory Requirements. (Q50100571)

24 February 2018

title

Bacteriophage Production in Compliance with Regulatory Requirements. (English)

1 reference

24 February 2018

1 reference

5

Gilbert Verbeken

1 reference

24 February 2018

Daniel De Vos

4

Daniel De Vos

1 reference

24 February 2018

Maia Merabishvili

2

Maia Merabishvili

1 reference

24 February 2018

Jean-Paul Pirnay

1

Jean-Paul Pirnay

1 reference

24 February 2018

Hilde Van Raemdonck

3

Hilde Van Raemdonck

1 reference

24 February 2018

language of work or name

English

0 references

publication date

1 January 2018

1 reference

24 February 2018

Methods in Molecular Biology

published in

1 reference

24 February 2018

volume

1693

1 reference

24 February 2018

page(s)

233-252

1 reference

24 February 2018

Effects of sequential and simultaneous applications of bacteriophages on populations of Pseudomonas aeruginosa in vitro and in wax moth larvae.

cites work

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-7395-8_18

Phage choice, isolation, and preparation for phage therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-7395-8_18

Call for a dedicated European legal framework for bacteriophage therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-7395-8_18

Bacteriophage therapy--cooked goose or phoenix rising?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-7395-8_18

DRUG DEVELOPMENT. Beleaguered phage therapy trial presses on.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-7395-8_18

Selection and characterization of a candidate therapeutic bacteriophage that lyses the Escherichia coli O104:H4 strain from the 2011 outbreak in Germany

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-7395-8_18

What are the limitations on the wider therapeutic use of phage?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-7395-8_18

Optimizing the European regulatory framework for sustainable bacteriophage therapy in human medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-7395-8_18

Production of mesenchymal stromal/stem cells according to good manufacturing practices: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-7395-8_18

The Developing World Urgently Needs Phages to Combat Pathogenic Bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-7395-8_18

Amplification and purification of T4-like escherichia coli phages for phage therapy: from laboratory to pilot scale

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-7395-8_18

Safety and efficacy of phage therapy via the intravenous route.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-7395-8_18

Quality-controlled small-scale production of a well-defined bacteriophage cocktail for use in human clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-7395-8_18

Phage treatment of human infections.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-7395-8_18

The antibody response to bacteriophage phi-X 174 in newborn premature infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-7395-8_18

Quality and safety requirements for sustainable phage therapy products

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-7395-8_18

Pirates of the Caudovirales

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-7395-8_18

Fosfomycin and rifampin disk diffusion tests for detection of Escherichia coli mutator strains

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-7395-8_18

Viunalikeviruses are environmentally common agents of horizontal gene transfer in pathogens and biocontrol bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-7395-8_18

A generalized transducing phage (phiIF3) for the genomically sequenced Serratia marcescens strain Db11: a tool for functional genomics of an opportunistic human pathogen

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-7395-8_18

Digitized fluorescent RFLP analysis (fRFLP) as a universal method for comparing genomes of culturable dsDNA viruses: application to bacteriophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-7395-8_18

Safety analysis of a Russian phage cocktail: from metagenomic analysis to oral application in healthy human subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-7395-8_18

Selection of phages and conditions for the safe phage therapy against Pseudomonas aeruginosa infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-7395-8_18

A genetic approach to the development of new therapeutic phages to fight pseudomonas aeruginosa in wound infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-7395-8_18

Reversing bacterial resistance to antibiotics by phage-mediated delivery of dominant sensitive genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-7395-8_18

Antibacterial efficacy of temperate phage-mediated inhibition of bacterial group motilities

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-7395-8_18

Bacteriophage treatment of intransigent diabetic toe ulcers: a case series

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-7395-8_18

The Phage Therapy Paradigm: Prêt-à-Porter or Sur-mesure?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-7395-8_18

10.1007/978-1-4939-7395-8_18

21 January 2018

Identifiers

DOI

1 reference

24 February 2018

PubMed ID

29119444

1 reference

24 February 2018